Article

Antimicrobial Activity of Human Prion Protein Is Mediated by Its N-Terminal Region

Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden.
PLoS ONE (Impact Factor: 3.53). 10/2009; 4(10):e7358. DOI: 10.1371/journal.pone.0007358
Source: PubMed

ABSTRACT Cellular prion-related protein (PrP(c)) is a cell-surface protein that is ubiquitously expressed in the human body. The multifunctionality of PrP(c), and presence of an exposed cationic and heparin-binding N-terminus, a feature characterizing many antimicrobial peptides, made us hypothesize that PrP(c) could exert antimicrobial activity.
Intact recombinant PrP exerted antibacterial and antifungal effects at normal and low pH. Studies employing recombinant PrP and N- and C-terminally truncated variants, as well as overlapping peptide 20mers, demonstrated that the antimicrobial activity is mediated by the unstructured N-terminal part of the protein. Synthetic peptides of the N-terminus of PrP killed the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, and the Gram-positive Bacillus subtilis and Staphylococcus aureus, as well as the fungus Candida parapsilosis. Fluorescence studies of peptide-treated bacteria, paired with analysis of peptide effects on liposomes, showed that the peptides exerted membrane-breaking effects similar to those seen after treatment with the "classical" human antimicrobial peptide LL-37. In contrast to LL-37, however, no marked helix induction was detected for the PrP-derived peptides in presence of negatively charged (bacteria-mimicking) liposomes. PrP furthermore showed an inducible expression during wounding of human skin ex vivo and in vivo, as well as stimulation of keratinocytes with TGF-alpha in vitro.
The demonstration of an antimicrobial activity of PrP, localisation of its activity to the N-terminal and heparin-binding region, combined with results showing an increased expression of PrP during wounding, indicate that PrPs could have a previously undisclosed role in host defense.

Download full-text

Full-text

Available from: Mukesh Pasupulti, Jun 23, 2015
0 Followers
 · 
281 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Biological efficiency of existing antimicrobial agents is still inadequate to ensure optimal therapeutic index. Developing biocompatible advanced functional materials with antimicrobial properties could be promising for environmentally benign applications. Nanoparticles and other nanoscale materials are of great interest due to their multiple potential applications in material science, medicine, and industry. Nanomaterials possess well renowned antimicrobial activity against several microorganisms; however, it has some non-specific toxicity. Biofunctionalization of nanomaterials is one such topic to address this issue. Rational selection of therapeutically active biomolecules for design of nanoparticles will certainly increase the biological applicability. The present paper describes the current status of different types of biofunctionalized nanoparticles and their antibacterial applications. Key principles such as strategies involved at bio-/nanointerface, the structural activity relationship, and mechanism of action involved in the antibacterial activity of functionalized nanoparticles are briefly discussed. This knowledge is important from the objective of generation of advanced functional nanomaterials with antimicrobial properties.
    Applied Microbiology and Biotechnology 06/2011; 90(5):1655-67. DOI:10.1007/s00253-011-3291-6 · 3.81 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The established association between polymorphisms of prnp prion gene and susceptibility to scrapie disease in sheep prompted the development of breeding programmes aimed at increasing the natural resistance to scrapie in the European Union. In order to study the possible undesirable consequences from the widespread selection for the prnp genotype on ovine genetic diversity and reproduction, we primarily focused our investigation in the ovine prnd gene which encodes a prion-like protein designated as Doppel that maps to the same chromosomal region as prnp, but is mainly expressed in testis. When prnd is overexpressed in the nervous tissue, Doppel is neurotoxic and causes neurodegenerative disease. We genotyped 460 animals (207 female and 253 male) from 8 Portuguese sheep breeds (Bordaleira entre Douro e Minho, Churra Badana, C. Galega Mirandesa, C. Mondegueira, Merino da Beira-Baixa, M. Branco, Saloia e Serra da Estrela), for prnp and prnd and established a parallel between a polymorphism in the prnd gene (78G>A) and scrapie susceptibility. We also identified an association between prnd polymorphisms and fertility traits. Upholding the emphasis on ovine reproduction, recombinant Doppel (rDpl) was supplemented in different concentrations to ram spermatozoa during the capacitation process. Regardless of dosage, rDpl improved sperm individual motility and vigour, and enhanced in vitro spermatozoa fertilizing ability. In addition, we determined by Nuclear Magnetic Resonance (NMR) spectroscopy the three-dimensional structure of the N-terminal (1-30) ovine Doppel (OvDpl) peptide, encompassing the 78G>A polymorphism and the entire signal peptide sequence. The new solved three-dimensional structure was subsequently used to construct molecular models with the M-domain of the signal recognition particle subunit (SRP54M). Simultaneously, we were able to obtain soluble mature Dpl protein through the co-expression with the SUMO chaperone. Finally, we developed a new polyclonal antibody (APPA) demonstrating for the first time that the recently discovered ovine prnt gene is a translated protein-coding gene and not a pseudogene, and identified through immunofluorescence and immunohistochemistry the location pattern of the encoded protein Prt in ram testis along spermatogenesis and in ejaculated spermatozoa. These results guided us to our last work, where data obtained through Prt blockage pointed to a physiological role for Prt in ovine fertilization (possibly through an interaction with zona pellucida proteins), reinforcing the importance of prion-like genes and proteins in the ovine reproductive physiology.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Transgenic mice expressing prion protein (PrP) molecules with several different internal deletions display spontaneous neurodegenerative phenotypes that can be dose-dependently suppressed by coexpression of wild-type PrP. Each of these deletions, including the largest one (Δ32-134), retains 9 aa immediately following the signal peptide cleavage site (residues 23-31; KKRPKPGGW). These residues have been implicated in several biological functions of PrP, including endocytic trafficking and binding of glycosaminoglycans. We report here on our experiments to test the role of this domain in the toxicity of deleted forms of PrP. We find that transgenic mice expressing Δ23-134 PrP display no clinical symptoms or neuropathology, in contrast to mice expressing Δ32-134 PrP, suggesting that residues 23-31 are essential for the toxic phenotype. Using a newly developed cell culture assay, we narrow the essential region to amino acids 23-26, and we show that mutant PrP toxicity is not related to the role of the N-terminal residues in endocytosis or binding to endogenous glycosaminoglycans. However, we find that mutant PrP toxicity is potently inhibited by application of exogenous glycosaminoglycans, suggesting that the latter molecules block an essential interaction between the N terminus of PrP and a membrane-associated target site. Our results demonstrate that a short segment containing positively charged amino acids at the N terminus of PrP plays an essential role in mediating PrP-related neurotoxicity. This finding identifies a protein domain that may serve as a drug target for amelioration of prion neurotoxicity.
    The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 09/2011; 31(39):14005-17. DOI:10.1523/JNEUROSCI.1243-11.2011 · 6.75 Impact Factor